Uncovering Systemic Lupus Erythematosus Candidate Proteomic Biomarkers: A Bioinformatics Approach
Journal of Cellular & Molecular Anesthesia,
Vol. 7 No. 1 (2022),
12 Esfand 2022
,
Page 40-48
https://doi.org/10.22037/jcma.v6i4.34797
Abstract
Introduction: Molecular analysis of different types of disease could be helpful to understand the mechanisms of the related abnormal functions at that level of disorder. Lupus is not an exception, by the use of protein-protein interaction network analysis, it is possible to investigate the molecular basis and malfunctions in this kind of disease.
Materials and methods: Thirteen proteins were explored for interaction purposes and some 12 central proteins were obtained via Cytoscape analysis.
Results: Among these proteins, three proteins were from the differentially expressed proteins or in other words reported biomarkers of lupus. These proteins include Haptoglobin (Hp), Apolipoprotein C-III (APOC3), and Apolipoprotein A-I (APOA1).
Discussion: It can be concluded that the biological processes of the central proteins could be part of Lupus's underlying mechanisms. Finally, validation studies are proposed by this current evaluation of the introduced panel of hub biomarkers.
- Systemic lupus erythematosus, Protein-protein interaction network analysis, Biological process
How to Cite
References
2. Catalina MD, Owen KA, Labonte AC, Grammer AC, Lipsky PE. The pathogenesis of systemic lupus erythematosus: harnessing big data to understand the molecular basis of lupus. Journal of autoimmunity. 2020;110:102359.
3. Nicolaou O, Sokratous K, Makowska Z, Morell M, De Groof A, Montigny P, et al. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis. Arthritis research & therapy. 2020;22(1):1-16.
4. Gordon C. Long‐term complications of systemic lupus erythematosus. Rheumatology. 2002;41(10):1095-100.
5. Li Y, Fang X, Li Q-Z. Biomarker profiling for lupus nephritis. Genomics, proteomics & bioinformatics. 2013;11(3):158-65.
6. Kuhn A, Bonsmann G, Anders H-J, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Deutsches Ärzteblatt International. 2015;112(25):423.
7. Fritzler MJ, Mahler M. Redefining systemic lupus erythematosus—SMAARTT proteomics. Nature Reviews Rheumatology. 2018;14(8):451-2.
8. Chun H-Y, Chung J-W, Kim H-A, Yun J-M, Jeon J-Y, Ye Y-M, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. Journal of clinical immunology. 2007;27(5):461-6.
9. Ramsey-Goldman R, Li J, Dervieux T, Alexander RV. Cell-bound complement activation products in SLE. Lupus science & medicine. 2017;4(1).
10. Wang H, Peng W, Ouyang X, Li W, Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Translational Research. 2012;160(3):198-206.
11. Motawi TK, Mohsen DA, El-Maraghy SA, Kortam MA. MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. Chemico-biological interactions. 2016;260:110-6.
12. Aljaberi N, Bennett M, Brunner HI, Devarajan P. Proteomic profiling of urine: implications for lupus nephritis. Expert review of proteomics. 2019;16(4):303-13.
13. Nicolaou O, Kousios A, Hadjisavvas A, Lauwerys B, Sokratous K, Kyriacou K. Biomarkers of systemic lupus erythematosus identified using mass spectrometry‐based proteomics: a systematic review. Journal of cellular and molecular medicine. 2017;21(5):993-1012.
14. Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V, Avihingsanon Y. Urinary proteomics revealed prostaglandin H2D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis. Journal of proteomics. 2012;75(11):3240-7.
15. Abrão ALP, Falcao DP, de Amorim RFB, Bezerra ACB, Pombeiro GAN, Guimarães LJ, et al. Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus. Medical hypotheses. 2016;89:97-100.
16. Zamanian-Azodi M, Rezaei-Tavirani* M, Esmaeili S, Rezaei Tavirani M. Bioinformatics Identification of Green Tea Anticancer Properties: a Network-Based Approach. Research Journal of Pharmacognosy. 2021;8(2):17-25.
17. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005;122(6):957-68.
18. Azodi MZ, Arjmand B, Razzaghi M, Tavirani MR, Ahmadzadeh A, Rostaminejad M. Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Bioinformatics Study. Archives of Academic Emergency Medicine. 2021;9(1):e27-e.
19. Zamanian Azodi M, Rezaei Tavirani M, Rezaei Tavirani M, Rostami Nejad M. Bioinformatics Investigation and Contribution of Other Chromosomes Besides Chromosome 21 in the Risk of Down Syndrome Development. Basic and Clinical Neuroscience. 2021;12(1):79-88.
20. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431-2.
21. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic acids research. 2015;43(D1):D447-D52.
22. Chen C, Shen H, Zhang L-G, Liu J, Cao X-G, Yao A-L, et al. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer. International journal of molecular medicine. 2016;37(6):1576-86.
23. Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282-4.
24. Tavirani MR, Azodi MZ, Rostami-Nejad M, Morravej H, Razzaghi Z, Okhovatian F, et al. Introducing Serine as cardiovascular disease biomarker candidate via pathway analysis. Galen Medical Journal. 2020;9:1696.
25. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091-3.
26. Bindea G, Galon J, Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29(5):661-3.
27. Abdi S, Azodi MZ, Rezaei-Tavirani M, Razzaghi M, Heidari MH, Baghban AA. Differentiation of H. pylori-negative and positive gastric cancer via regulatory network analysis. Gastroenterology and hepatology from bed to bench. 2020;13(2):161.
28. Nigolian H, Ribi C, Courvoisier DS, Pagano S, Alvarez M, Trendelenburg M, et al. Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus. Rheumatology. 2020;59(3):534-44.
29. Gaál K, Tarr T, Lőrincz H, Borbás V, Seres I, Harangi M, et al. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids in health and disease. 2016;15(1):1-8.
30. Chistiakov DA, Orekhov AN, Bobryshev YV. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease. Laboratory Investigation. 2016;96(7):708-18.
31. Croca S, Davari M, Isenberg D, Rahman A, editors. Serum anti-apolipoprotein 1 antibodies are present in a quarter of patients with systemic lupus erythematosus at the time of diagnosis and are associated with earlier mortality. Rheumatology; 2014: OXFORD UNIV PRESS.
32. Aggarwal A, Gupta R, Negi V, Rajasekhar L, Misra R, Singh P, et al. Urinary haptoglobin, alpha‐1 anti‐chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis. Clinical & Experimental Immunology. 2017;188(2):254-62.
33. Madda R, Lin S-C, Sun W-H, Huang S-L. Plasma proteomic analysis of systemic lupus erythematosus patients using liquid chromatography/tandem mass spectrometry with label-free quantification. PeerJ. 2018;6:e4730.
34. Timlin H, Machireddy K, Petri M. Low level of haptoglobin in lupus. Journal of investigative medicine high impact case reports. 2017;5(1):2324709616689106.
35. Galicia G, Ceuppens JL. Haptoglobin function and regulation in autoimmune diseases. Acute Phase Proteins-Regulation and Functions of Acute Phase Proteins. 2011:229-46.
36. Morgan PE, Sturgess AD, Hennessy A, Davies MJ. Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free radical research. 2007;41(12):1301-12.
- Abstract Viewed: 161 times
- PDF Downloaded: 170 times